Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 3
1973 1
1974 3
1975 1
1976 2
1978 2
1979 1
1980 1
1981 1
1982 4
1983 3
1984 4
1985 3
1986 4
1987 3
1988 8
1989 5
1990 6
1991 7
1992 6
1993 2
1994 5
1995 5
1996 4
1997 1
1998 3
1999 3
2000 2
2002 1
2003 2
2004 1
2005 9
2006 3
2007 15
2008 34
2009 28
2010 14
2011 14
2012 29
2013 18
2014 5
2015 8
2016 2
2017 3
2018 6
2019 4
2020 8
2021 12
2022 16
2023 20
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Results by year

Filters applied: . Clear all
Page 1
Green genes gleaned.
Beale SI. Beale SI. Trends Plant Sci. 2005 Jul;10(7):309-12. doi: 10.1016/j.tplants.2005.05.005. Trends Plant Sci. 2005. PMID: 15951223
SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort.
Aldridge RW, Yavlinsky A, Nguyen V, Eyre MT, Shrotri M, Navaratnam AMD, Beale S, Braithwaite I, Byrne T, Kovar J, Fragaszy E, Fong WLE, Geismar C, Patel P, Rodger A, Johnson AM, Hayward A. Aldridge RW, et al. Among authors: beale s. Nat Commun. 2022 Aug 18;13(1):4869. doi: 10.1038/s41467-022-32265-5. Nat Commun. 2022. PMID: 35982056 Free PMC article.
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Houten R, Greenhalgh J, Mahon J, Nevitt S, Beale S, Boland A, Lambe T, Dundar Y, Kotas E, McEntee J. Houten R, et al. Among authors: beale s. Pharmacoecon Open. 2021 Mar;5(1):13-22. doi: 10.1007/s41669-020-00206-x. Pharmacoecon Open. 2021. PMID: 32291725 Free PMC article. Review.
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Bresnahan R, Houten R, Greenhalgh J, Nevitt S, Mahon J, Beale S, Boland A, Bhattacharyya D, Dundar Y, McEntee J, Gandhi S, Fleeman N, Chaplin M. Bresnahan R, et al. Among authors: beale s. Pharmacoecon Open. 2023 Jul;7(4):525-536. doi: 10.1007/s41669-023-00408-z. Epub 2023 May 17. Pharmacoecon Open. 2023. PMID: 37195551 Free PMC article. Review.
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Stainthorpe A, Fleeman N, Houten R, Chaplin M, Boland A, Beale S, Dundar Y, McEntee J, Syndikus I. Stainthorpe A, et al. Among authors: beale s. Pharmacoecon Open. 2020 Dec;4(4):563-574. doi: 10.1007/s41669-020-00203-0. Pharmacoecon Open. 2020. PMID: 32207075 Free PMC article. Review.
341 results